1. Introduction {#sec1-marinedrugs-14-00056}
===============

Chronic overuse of alcohol can lead to brain tissue damage and cognitive dysfunction \[[@B1-marinedrugs-14-00056]\]. Studies have shown that heavy drinking is associated with increased risk and earlier onset of dementia such as Alzheimer's disease \[[@B2-marinedrugs-14-00056],[@B3-marinedrugs-14-00056]\]. Ethanol is metabolized to acetaldehyde following consumption by alcohol dehydrogenase (ADH). In the brain, catalase and cytochrome p450 2E1 are additional enzymes that are critical for the local formation of acetaldehyde \[[@B4-marinedrugs-14-00056]\]. Acetaldehyde is further oxidized to acetate by aldehyde dehydrogenase (ALDH) 2. The level of acetaldehyde in blood elevates upon overconsumption of alcohol. Individuals with defective ALDH2 have much higher blood acetaldehyde levels after drinking alcohol in comparison with normal individuals \[[@B5-marinedrugs-14-00056]\].

Evidence has shown that acetaldehyde is the most toxic metabolite of ethanol. In various cell types, acetaldehyde is found to induce cytotoxicity and apoptosis \[[@B6-marinedrugs-14-00056],[@B7-marinedrugs-14-00056]\]. Studies using cell or animal models deficient in ALDH2 or overexpressing ADH have shown that the cell damages and tissue injuries induced by alcohol are mediated by its metabolite acetaldehyde \[[@B8-marinedrugs-14-00056],[@B9-marinedrugs-14-00056]\]. In central nervous system, it has been demonstrated that accumulation of acetaldehyde mediates the brain tissue damage and the cognitive dysfunction induced by chronic excessive consumption of alcohol. Locally-generated acetaldehyde is shown to mediate the acute inhibition of long-term potentiation by ethanol in the CA1 region of rat hippocampal slices and may contribute to the synaptic dysfunction \[[@B10-marinedrugs-14-00056]\]. In rat embryos, acetaldehyde treatment induces marked cell death in several tissues including neuroepithelium, correlating to the malformations seen in fetal alcohol syndrome (FAS) \[[@B11-marinedrugs-14-00056]\]. Acetaldehyde treatment also causes decrease in cell viability in rat cerebellar neuron cultures \[[@B12-marinedrugs-14-00056]\]. It has been shown that the cytotoxic effects of acetaldehyde are attributed to its induction of oxidative stress, mitochondrial dysfunction and activation of apoptotic signals such as cytochrome *c* release and caspase activation \[[@B12-marinedrugs-14-00056],[@B13-marinedrugs-14-00056],[@B14-marinedrugs-14-00056]\].

Astaxanthin (Ast) is a carotenoid that occurs naturally in a wide variety of organisms such as microalgae, yeast, salmon, trout, shrimp and crayfish. Currently, Ast is primarily produced from the green algae *Haematococcus pluvialis* and the red yeast *Phaffia rhodozyma* \[[@B15-marinedrugs-14-00056]\]. Ast has strong antioxidant properties. Studies have shown that Ast can effectively scavenge oxygen free radicals and is able to reduce lipid peroxidation and oxidative stress and inhibit reactive oxygen species (ROS)-mediated cytoxicity in both cell and animal models \[[@B16-marinedrugs-14-00056],[@B17-marinedrugs-14-00056],[@B18-marinedrugs-14-00056],[@B19-marinedrugs-14-00056]\]. The function of Ast has been associated with a number of health-promoting benefits, including immunomodulation, prevention and treatment of cardiovascular diseases and cancer \[[@B20-marinedrugs-14-00056],[@B21-marinedrugs-14-00056],[@B22-marinedrugs-14-00056]\]. In addition, it has been reported that Ast reduces ischemic brain injury by inhibiting ischemia-mediated oxidative stress, glutamate release and apoptosis in the brain tissue in animal models \[[@B23-marinedrugs-14-00056],[@B24-marinedrugs-14-00056]\]. Ast treatment has also been shown to suppress 6-hydroxyldopamine and glutamate-induced apoptosis in neuronal cells via attenuating pro-apoptotic signaling pathways and activating the expression of antioxidative enzymes \[[@B25-marinedrugs-14-00056],[@B26-marinedrugs-14-00056]\]. These studies clearly demonstrate that Ast has neuroprotective functions.

As mentioned above, local accumulation of acetaldehyde is speculated to mediate the neurotoxic effects and brain tissue damages induced by chronic excessive consumption of alcohol. However, there are few reports regarding whether Ast can inhibit acetaldehyde-induced cytotoxicity in neuronal cells. In this study, we investigated the effects of Ast on acetaldehyde-induced cytotoxicity in human neuroblastoma SH-SY5Y cells. It was found that astaxanthin inhibited acetaldehyde-induced loss of cell viability and apoptosis. Ast treatment ameliorated the effect of acetaldehyde on the expression of Bcl-2 family proteins, preventing the reduction of anti-apoptotic protein Bcl-2 and increase of pro-apoptotic protein Bak induced by acetaldehyde. Further analyses showed that astaxanthin treatment attenuated acetaldehyde-induced reduction of the levels of activated Akt and cyclic AMP-responsive element binding protein (CREB). Ast treatment also prevented acetaldehyde-induced increase of the level of activated p38 mitogen-activated protein kinase (MAPK) and decrease of the level of activated extracellular signal-regulated kinases (ERKs). In addition, astaxanthin treatment suppressed the oxidative stress induced by acetaldehyde and restored the antioxidative capacity in SH-SY5Y cells. Therefore, astaxanthin may protect cells against acetaldehyde-induced cytotoxicity via inhibition of apoptotic signaling, promotion of cell survival pathway and suppression of oxidative stress.

2. Results {#sec2-marinedrugs-14-00056}
==========

2.1. Ast Reduces Acetaldehyde-Induced Cytotoxicity and Apoptosis {#sec2dot1-marinedrugs-14-00056}
----------------------------------------------------------------

It has been shown that acetaldehyde induces cytotoxicity in rat cerebellar primary neuronal cultures in a dose dependent manner \[[@B12-marinedrugs-14-00056]\]. Similarly, we have observed that acetaldehyde treatment decreases the cell viability of SH-SY5Y cells \[[@B27-marinedrugs-14-00056]\]. Here we tested the effects of Ast on the viability of SH-SY5Y cells stimulated with acetaldehyde. As shown in [Figure 1](#marinedrugs-14-00056-f001){ref-type="fig"}a, after 24 h of acetaldehyde treatment, the cell viability was reduced to about 60% of the control cells. Ast pretreatment significantly inhibited acetaldehyde-induced loss of cell viability, leading to a 65% increase of viability in comparison to the cells treated with acetaldehyde only. Hoechst 33258 staining demonstrated that acetaldehyde induced apoptosis in SH-SY5Y cells while pre-incubation with Ast markedly decreased the number of apoptotic cells induced by acetaldehyde ([Figure 1](#marinedrugs-14-00056-f001){ref-type="fig"}b). These results showed that AST treatment was able to prevent acetaldehyde-induced cytotoxicity and apoptosis in SH-SY5Y cells.

Caspase 3 is a hallmark of the late apoptotic events. As shown in [Figure 2](#marinedrugs-14-00056-f002){ref-type="fig"}a, acetaldehyde significantly increased the activity of caspase 3 by nearly 12.5 folds, while Ast pretreatment inhibited acetaldehyde-induced activity of caspase 3 by nearly 40%. Mitochondria apoptosis pathway is mainly regulated by Bcl-2 family proteins via affecting the permeability of mitochondria membrane \[[@B28-marinedrugs-14-00056],[@B29-marinedrugs-14-00056]\]. Thus, we next examined the effect of Ast on the expression of Bcl-2 family proteins. As shown in [Figure 2](#marinedrugs-14-00056-f002){ref-type="fig"}b, the level of Bcl-2 protein was increased slightly but not significantly by Ast treatment alone. Surprisingly, we also observed that Ast treatment alone caused an increase in the level of Bak protein ([Figure 2](#marinedrugs-14-00056-f002){ref-type="fig"}c). Exposure of SH-SY5Y cells to acetaldehyde for 24 h resulted in a decrease in Bcl-2 protein level by nearly 60%, while Ast pretreatment attenuated the loss of Bcl-2 protein ([Figure 2](#marinedrugs-14-00056-f002){ref-type="fig"}b). Meanwhile, acetaldehyde exposure increased the protein level of Bak to nearly eight folds of the control cells, while Ast pretreatment markedly decreased this acetaldehyde-induced upregulation of Bak by approximately 50% ([Figure 2](#marinedrugs-14-00056-f002){ref-type="fig"}c). These data suggested that AST might inhibit acetaldehyde-induced apoptosis of SH-SY5Y cells by modulating apoptotic signals including the expression of Bcl-2 family proteins and the activation of caspases.

2.2. AST Ameliorates Acetaldehyde-Induced Inhibition of Akt and CREB {#sec2dot2-marinedrugs-14-00056}
--------------------------------------------------------------------

The phosphorylation and activation of Akt/CREB pathway are important for the survival of neuronal cells \[[@B30-marinedrugs-14-00056],[@B31-marinedrugs-14-00056]\]. To examine whether Ast protects cells from acetaldehyde-induced cytotoxicity by promoting the Akt/CREB pathway, the levels of activated Akt and CREB were determined by Western blot analyses. As shown in [Figure 3](#marinedrugs-14-00056-f003){ref-type="fig"}, acetaldehyde markedly decreased the levels of activated of Akt and CREB, by approximately 70% and 34%, respectively, while this reduction of activated Akt and CREB was significantly attenuated by Ast pretreatment ([Figure 3](#marinedrugs-14-00056-f003){ref-type="fig"}a,b). These data suggested that Ast might inhibit acetaldehyde-induced cytotoxicity and apoptosis at least partly through preventing the decrease of the levels of activated Akt and CREB in cells treated with acetaldehyde.

2.3. Effects of AST on the Activation of MAPKs in Acetaldehyde-Treated Cells {#sec2dot3-marinedrugs-14-00056}
----------------------------------------------------------------------------

MAPKs have been shown to have important roles in promotion or inhibition of apoptosis. We next examined the effects of Ast on the activation of p38MAPK and ERK pathways in acetaldehyde-treated cells by Western blot analyses. Treatment of acetaldehyde dramatically increased the level of activated p38MAPK by approximately 44%, while Ast pretreatment for 24 h blocked this increase of activated p38MAPK, almost restoring it to the same level of that in control cells ([Figure 4](#marinedrugs-14-00056-f004){ref-type="fig"}a). In contrast, acetaldehyde treatment caused a down regulation of the levels of activated ERK1 and ERK2 by approximately 46% and 19%, respectively, while Ast pretreatment significantly inhibited the increase of the level of activated ERK1 and ERK2, by 46% and 28%, respectively ([Figure 4](#marinedrugs-14-00056-f004){ref-type="fig"}b). These data showed that Ast could block acetaldehyde-induced changes in the levels of activated p38MAPK and ERKs.

2.4. Ast Reduces Acetaldehyde-Induced Oxidative Stress {#sec2dot4-marinedrugs-14-00056}
------------------------------------------------------

Acetaldehyde has been shown to induce oxidative stress in neuronal cells \[[@B12-marinedrugs-14-00056]\]. Here we detected a quick and dramatic increase in the levels of ROS at 1h after exposure of acetaldehyde in SH-SY5Y cells. The induction of ROS production by acetaldehyde was greatly suppressed by the pretreatment of Ast ([Figure 5](#marinedrugs-14-00056-f005){ref-type="fig"}a). Similarly, Ast also significantly reduced the level of malondialdehyde (MDA), a marker of lipid peroxidation and intracellular oxidative stress \[[@B32-marinedrugs-14-00056]\], in acetaldehyde treated SH-SY5Y cells ([Figure 5](#marinedrugs-14-00056-f005){ref-type="fig"}b). Tripetide glutathione (GSH) is important for the detoxification of ROS and maintenance of redox status in the cell. It has been shown that GSH levels are significantly reduced at 2 h after acetaldehyde treatment in SH-SY5Y cells \[[@B27-marinedrugs-14-00056]\]. As shown in [Figure 5](#marinedrugs-14-00056-f005){ref-type="fig"}c, Ast treatment prevented the decrease of the level of GSH induced by 5 mM acetaldehyde. The effect of astaxanthin on the levels of GSH was also tested in cells treated with 10 mM acetaldehyde; however, it was found that there was no significant effect of astaxanthin on acetaldehyde-induced reduction of GSH. As treatment with 5 mM and 10 mM acetaldehyde caused approximately 30% and 50% decrease in the levels of GSH, respectively, it was possible that the antioxidative capacity increased by astaxanthin might not be large enough to significantly prevent the reduction of GSH by 10 mM acetaldehyde. Nonetheless, these data suggested that Ast treatment attenuated the intracellular oxidative stress induced by acetaldehyde. As oxidative stress plays an important role in acetaldehyde-induced apoptosis and cytotoxicity, the antioxidant property of Ast may contribute greatly to the protective effect of Ast on acetaldehyde-induced cytotoxicity of SH-SY5Y cells.

3. Discussion {#sec3-marinedrugs-14-00056}
=============

Acetaldehyde has been speculated to mediate the brain tissue damage and cognitive dysfunction induced by chronic alcohol overuse. Local accumulation of acetaldehyde in the brain can lead to neurotoxicity and perhaps contribute to the acceleration of the development of neurodegenerative disease. It has been shown that acetaldehyde induces neurotoxic effects by activating apoptotic signals such as downregulation of anti-apoptotic Bcl-2 family proteins and activation of caspases \[[@B12-marinedrugs-14-00056],[@B13-marinedrugs-14-00056],[@B33-marinedrugs-14-00056]\]. In this study, it was demonstrated that AST, a marine bioactive compound, protected neuronal cells from acetaldehyde induced apoptosis and cytotoxicity.

In response to apoptotic stimuli, pro-apoptotic Bcl-2 family proteins such as Bak are converted to oligomers that form large pores in the mitochondrial outer membrane, resulting in the release of apoptotic factors including cytochrome *c* into the cytoplasm and initiating a cascade of apoptotic events that lead to cell death \[[@B34-marinedrugs-14-00056]\]. In contrast, pro-survival Bcl-2 family protein such as Bcl-2 function in preventing the oligomerization and promoting the cytosol re-translocation of pro-apoptotic Bcl-2 family proteins, thus stabilizing mitochondrial membrane and preserving mitochondrial integrity, leading to the inhibition of apoptotic events \[[@B29-marinedrugs-14-00056]\]. Here it was shown that Ast ameliorated the effect of acetaldehyde on levels of Bcl-2 family proteins, inhibiting the reduction of Bcl-2 and increase of Bak induced by acetaldehyde. Thus, Ast might protect the cells from acetaldehyde-induced apoptosis by modulating the levels of pro-survival and pro-apoptotic Bcl-2 family proteins. In addition, it was found that Ast significantly decreased the acetaldehyde-stimulated caspase 3 activities. As Bcl-2 family proteins play key roles in regulating the expression and activation of caspase 3 \[[@B35-marinedrugs-14-00056]\], the decrease of caspase-3 activities by AST might be a result from its prevention of the downregulation of pro-survival Bcl-2 family proteins.

To our surprise, we found that astaxanthin treatment alone increased the level of Bak protein. It has been documented that Ast has anti-tumor activity \[[@B20-marinedrugs-14-00056]\]. In human and rat hepatocellular carcinoma cells, Ast has been shown to induce apoptosis while down-regulating anti-apoptotic Bcl-2 protein \[[@B36-marinedrugs-14-00056],[@B37-marinedrugs-14-00056]\]. The concentrations of Ast used in these studies were at least 100 times higher than that used in our study, suggesting that Ast may promote cell survival at lower concentration but induce apoptosis at higher concentration. It is also possible that the effect of Ast on cell survival and apoptosis is cell specific, thus causing the contradictory results seen in different studies. No direct evidence has been shown that Ast modulates the expression of *bak* gene. It has been reported that p53 is involved in the induction of *bak* \[[@B38-marinedrugs-14-00056]\]. Recently, it has been shown that Ast increases the expression of p53 while blocking the oxidative stress-induced apoptosis in alveolar epithelial cells \[[@B39-marinedrugs-14-00056]\]. Therefore, it would be interesting to know whether p53 is elevated in Ast-treated SH-SY5Y cells and whether Ast modulates the expression of Bak at transcriptional level.

The serine/threonine kinase Akt is a key player in regulating cell signals that are important for cell death and survival \[[@B30-marinedrugs-14-00056]\]. It has been shown that active Akt protects SH-SY5Y cells against apoptosis through maintaining mitochondrial membrane potential and preventing the release of cytochrome *c* from mitochondria and the activation of caspases \[[@B40-marinedrugs-14-00056]\]. In this study, Ast treatment blocked acetaldehyde-induced reduction of activated Akt levels in SH-SY5Y cells. Transcription factor CREB is a downstream substrate of Akt. The phosphorylation of CREB by Akt on Ser133 results in its transcriptional activation and inhibition of apoptosis \[[@B31-marinedrugs-14-00056],[@B41-marinedrugs-14-00056]\]. Consistently, we observed that decrease of the levels of activated CREB was attenuated by Ast treatment. CREB promotes cell survival via a transcription-dependent mechanism, upregulating the expression of anti-apoptotic genes such as Bcl-2 \[[@B42-marinedrugs-14-00056],[@B43-marinedrugs-14-00056]\]. Thus, Ast may inhibit acetaldehyde-induced downregulation of Bcl-2 by preventing the decrease of the activated CREB. These results suggest that Ast may improve the survival of cells treated by acetaldehyde via attenuating acetaldehyde-induced inhibition of Akt/CREB pathway.

It has been shown that p38MAPK is activated during 6-hydroxydopamine-induced apoptosis and plays a critical role in promoting apoptotic events in SH-SY5Y cells \[[@B44-marinedrugs-14-00056]\]. Previously, we have reported that acetaldehyde treatment induces p38MAPK activation in a dose dependent manner \[[@B27-marinedrugs-14-00056]\]. Here we observed that Ast treatment significantly reduced the increase of activated p38MAPK induced by acetaldehyde. Similarly, Ast has been found to inhibit the activation of p38MAPK induced by 6-hydroxydopamine or Abeta 25-35 and prevent the loss of cell viability \[[@B25-marinedrugs-14-00056],[@B45-marinedrugs-14-00056]\]. Thus, blocking the activation of p38MAPK may be critical for the neuroprotective effect of Ast. In contrast, it was found that acetaldehyde treatment caused reduction in the levels of activated ERKs, which was largely prevented by Ast pretreatment. As the elevation of activated ERKs has been shown to mediate the inhibition of apoptosis in cultured hippocampal neurons and endothelial cells \[[@B46-marinedrugs-14-00056],[@B47-marinedrugs-14-00056]\], prevention of the loss of activated ERKs may be another mechanism by which Ast inhibits the apoptosis induced by acetaldehyde. It has been reported that the activation of p38MAPK is involved in the suppression of PI3K/Akt signaling pathway and CREB mediated Bcl-2 expression \[[@B48-marinedrugs-14-00056],[@B49-marinedrugs-14-00056]\], while treating cells with ERK inhibitor attenuates the activation of Akt \[[@B50-marinedrugs-14-00056],[@B51-marinedrugs-14-00056]\]. Thus, the inhibition of the activation of p38MAPK and the recovery of ERK activation by Ast treatment may also play a role in modulation of Akt/CREB mediated cell signaling in acetaldehyde-treated cells, eventually leading to the promotion of cell survival.

Oxidative stress is an early event and an important factor in acetaldehyde-induced cytotoxicity and \[[@B12-marinedrugs-14-00056],[@B13-marinedrugs-14-00056],[@B14-marinedrugs-14-00056],[@B27-marinedrugs-14-00056]\]. Ast pre-treatment significantly decreased the production of ROS and MDA while restoring the level of GSH, indicating a significant reduction of oxidative stress in cells treated by acetaldehyde. Therefore, the antioxidant property of Ast may contribute to the protective effect of Ast on acetaldehyde-induced cytotoxicity of SH-SY5Y cells. It is known that ROS stimulates cellular responses involved in both adaptive survival and death including the activation of MAPK and Akt pathways \[[@B52-marinedrugs-14-00056],[@B53-marinedrugs-14-00056]\]. By restoring the redox balance of the cells, Ast may modulate the cell signals in a way that inhibits apoptosis and promotes cell survival.

Overall, the results suggest that Ast may inhibit acetaldehyde-induced apoptosis and cytotoxicity by reducing the oxidative stress, preventing the activation of p38 MAPK, and attenuating the inhibition of ERK and Akt/CREB mediated cell signals in acetaldehyde-treated cells ([Figure 6](#marinedrugs-14-00056-f006){ref-type="fig"}).

4. Materials and Methods {#sec4-marinedrugs-14-00056}
========================

4.1. Materials {#sec4dot1-marinedrugs-14-00056}
--------------

Fetal bovine serum (FBS), streptomycin and penicillin were purchased from Thermo Scientific (Rockford, IL, USA). Dulbecco's modified eagle's medium (DMEM) and trypsin were purchased from Invitrogen (Eugene, OR, USA). Ast (3*S*,3′*S*-dihydroxy-β,β-carotene-4,4′-dione) was purchased from Cayman Chemical Company (Ann Arbor, MI, USA). Dimethyl sulfoxide (DMSO) was used as the solvent for Ast. Caspase 3 activity kit, bicinchoninic acid (BCA) protein assay kit, DMSO, BeyoECL plus Western blotting detection system, anti-Akt, donkey anti-goat IgG (H+L) and goat anti-rabbit IgG (H+L) antibodies were purchased from Beyotime Institute of Biotechnology (Haimen, China). MDA assay kit and GSH assay kit were purchased from Nanjing Jiancheng Bioengineering Institute (Nanjing, China). Brandford protein assay kit and anti-phospho-Akt (Ser473) antibody were purchased from Sangon Biotech (Shanghai, China). DCFH-DA was purchased from Sigma Chemical (St. Louis, MO, USA). Antibodies for CREB, phospho-CREB (Ser133), p38MAPK, phospho-p38MAPK (Thr180/Tyr182), p44/p42 MAPK, phospho-p44/p42MAPK (Thr202/Tyr204) were purchased from Cell Signaling Technology (Beverly, MA, USA). Antibody for Bak was purchased from Wanleibio Co., Ltd. (Shanghai, China). Antibody for Bcl-2 was purchased from Boster Institute of Biotechnology (Wuhan, China). Antibody for actin was purchased from Santa Cruz Biotechnology (Dallas, TX, USA).

4.2. Cell Viability Assay {#sec4dot2-marinedrugs-14-00056}
-------------------------

Human neuroblastoma SH-SY5Y cells were maintained in DMEM with 10% FBS, 1% streptomycin/penicillin in a CO~2~ incubator at 37 °C, with 5% CO~2~ and 95% air. Cells were seeded in 12-well plates with a density of 4 × 10^4^ per well. The viability of cells was checked by trypan blue exclusion assay.

4.3. Hoechst 33258 Nuclear Staining Assay {#sec4dot3-marinedrugs-14-00056}
-----------------------------------------

Apoptotic cells were detected by Hoechst 33258 nuclear staining assay. Cells were fixed for 10 min at room temperature after treatments. The fixed cells were incubated with Hoechst 33258 for 5 min at room temperature and subsequently washed with PBS for three times in the dark. The fluorescence was examined using an Olympus BX53 fluorescence microscope.

4.4. Caspase 3 Activity {#sec4dot4-marinedrugs-14-00056}
-----------------------

The activity of caspase 3 was determined using a caspase 3 activity kit according to the manufacturer's instructions. After treatments, cells were harvested by digesting with trypsin and cell lysates were prepared. To evaluate the activity of caspase 3, cell lysates were incubated with Ac-DEVD-pNA and reaction buffer for 10 h at 37 °C. Substrate cleavage was then measured using a spectrometer at 405 nm.

4.5. Measurement of Intracellular Oxidation Stress {#sec4dot5-marinedrugs-14-00056}
--------------------------------------------------

Fluorescent probe DCFH-DA was used to determine the changes of the intracellular generation of ROS. After treatments, cells were rinsed three times with PBS, and incubated with 5 μM DCFH-DA at 37 °C for 30 min. The fluorescence was examined using an Olympus BX53 fluorescence microscope.

For determining the concentrations of MDA and GSH, cells were harvested after the treatments by trypsinization and the total cell lysates were collected. The levels of MDA and GSH in the samples were determined using commercial available kits according to the manufacturer's instructions. Lipid peroxidation was evaluated by the reaction of MDA with thiobarbituric acid to form a product that was measured at 532 nm using a spectrometer. For assays of GSH, samples were first deproteinized. The levels of GSH were then measured by the reaction of the sulfhydryl group of GSH with 5,5′-dithio-bis-2-nitrobenzoic acid (DTNB) to form a yellow colored product that was measured at 405 nm using a spectrometer. Protein concentrations were determined by the BCA protein assay, and the levels MDA and GSH were normalized by the amount of protein in the total cell lysates.

4.6. Western Blotting Analysis {#sec4dot6-marinedrugs-14-00056}
------------------------------

After treatments, cells were washed twice with PBS and the cell lysates were prepared in cell lysis buffer (Tris 20 mM, NaCl 150 mM, EDTA 1 mM, sodium pyrophosphate 2.5 mM, NaF 20 mM, β-glycerophosphoric acid 1 mM, sodium orthovanadate 1 mM). The supernatants were collected after centrifugation at 14,000× *g* for 10 min at 4 °C and the protein concentration of supernatants was measured. Twenty micrograms of protein extracts were resolved by SDS-polyacrylamide gel electrophoresis then transferred to polyvinylidene difluoride (PVDF) membrane and subsequently incubated with specific primary antibodies. PVDF membrane was washed by Tris buffered saline (TBS) containing 0.1% Tween-20 for three times. For detection, the PVDF membrane was incubated with a horseradish peroxidase-coupled secondary antibody, followed by an enhanced chemiluminescence substrate reaction using BeyoECL plus Western blotting detection system.

4.7. Statistical Analysis {#sec4dot7-marinedrugs-14-00056}
-------------------------

All the experiments were carried out in triplicates. Quantitative data are represented as the mean ± SD. Statistical analysis of the data was performed by two-way ANOVA. Least significant difference (LSD) test was used for pairwise comparisons. *p* values of 0.05 were considered statistically significant.

5. Conclusions {#sec5-marinedrugs-14-00056}
==============

In summary, Ast treatment is effective in preventing acetaldehyde-induced cytotoxicity in SH-SY5Y cells. In addition, Ast may inhibit acetaldehyde-induced cytotoxicity via inhibition of apoptotic signaling, promotion of cell survival pathways, and suppression of oxidative stress. The study provides evidence that Ast treatment may be beneficial for preventing neurotoxicity associated with acetaldehyde and excessive alcohol consumption.
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![Effects of Ast on acetaldehyde-induced cytotoxicity and apoptois in SH-SY5Y cells. (**a**) Cells incubated with vehicle or 50 ng/mL Ast for 24 h were incubated with 10 mM acetaldehyde for 24 h. Cell viability was determined by trypan blue assay; (**b**) Cells were fixed and stained with Hoechst 33258. Values are means ± SD from three independent experiments. \* Significantly different from control group (*p* \< 0.05); \# significantly different from acetaldehyde-treated group (*p* \< 0.05).](marinedrugs-14-00056-g001){#marinedrugs-14-00056-f001}

![Effects of Ast on acetaldehyde-induced apoptotic signaling in SH-SY5Y cells. Cells incubated with vehicle or 50 ng/mL Ast for 24 h were treated with 10 mM acetaldehyde for 24 h. (**a**) Total lysates of cells were collected and the caspase 3 activities were determined; (**b**,**c**) Total cell lysates were collected and the amount of Bcl-2 and Bak was determined by Western blot analyses. The intensities of the bands were quantified by densitometric analyses and normalized by the amount of actin. Values are means ± SD from three independent experiments. \* Significantly different from control group (*p* \< 0.05); \# significantly different from acetaldehyde-treated group (*p* \< 0.05).](marinedrugs-14-00056-g002){#marinedrugs-14-00056-f002}

![Ast treatment attenuates the inhibition of Akt and CREB induced by acetaldehyde in SH-SY5Y cells. Cells incubated with vehicle or 50 ng/mL Ast for 24 h were treated with acetaldehyde for 24 h. Total cell lysates were collected and the amount of Akt, phospho-Akt (Ser473), (**a**) CREB and phospho-CREB (Ser 133) (**b**) was determined by Western blot analyses. The intensities of the bands were quantified by densitometric analyses and normalized by the amount of Akt or CREB. Values are means ± SD from three independent experiments. \* Significantly different from control group (*p* \< 0.05); \# significantly different from acetaldehyde-treated group (*p* \< 0.05).](marinedrugs-14-00056-g003){#marinedrugs-14-00056-f003}

![Effects of Ast on the activation of p38MAPK/ERKs in acetaldehyde-treated SH-SY5Y cells. Cells incubated with vehicle or Ast for 24 h were treated with acetaldehyde for another 24 h. Total cell lysates were collected and the protein levels of p38MAPK and phosho-p38MAPK (Thr180/Tyr182), (**a**) ERK (p44/p42) and phospho-ERK (Thr202/Tyr204); (**b**) were determined by Western blot analyses. The intensities of the bands were quantified by densitometric analyses and normalized by the amount of p38MAPK or ERK (p44/p42). Values are means ± SD from three independent experiments. \* Significantly different from control group (*p* \< 0.05); \# significantly different from acetaldehyde-treated group (*p* \< 0.05).](marinedrugs-14-00056-g004){#marinedrugs-14-00056-f004}

![Effect of Ast on acetaldehyde-induced oxidative stress in SH-SY5Y cells. (**a**) Cells preincubated with vehicle or 50 ng/mL Ast were treated with 10 mM of acetaldehyde for 1 h. Cells were then stained with 2′,7′-dichlorodihydrofluorescin diacetate (DCFH-DA) to determine the production of ROS; (**b**) Cells preincubated with vehicle or 50 ng/mL Ast were treated with 10 mM acetaldehyde for 24 h. MDA production was measured in the cell lyates; (**c**) Cells preincubated with vehicle or 50 ng/mL Ast were treated with 5 mM of acetaldehyde for 2 h. The levels of reduced GSH were determined in the cell lyates. Values are means ± SD from three independent experiments. \* Significantly different from control group (*p* \< 0.05); \# significantly different from acetaldehyde-treated group (*p* \< 0.05).](marinedrugs-14-00056-g005){#marinedrugs-14-00056-f005}

![Possible mechanisms by which Ast inhibits acetaldehyde-induced apoptosis and cytotoxicity.](marinedrugs-14-00056-g006){#marinedrugs-14-00056-f006}
